Cargando…

The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery

BACKGROUND AND AIMS: Epicardial and pericardial adipose tissue (EAT and PAT) associate with atherosclerosis, however, discussed to have different inflammatory properties. We examined the NLRP3 inflammasome related pathway, playing a pivotal role in atherosclerosis, in EAT, PAT and subcutaneous AT (S...

Descripción completa

Detalles Bibliográficos
Autores principales: Åkra, Sissel, Seljeflot, Ingebjørg, Braathen, Bjørn, Bratseth, Vibeke, Hansen, Charlotte Holst, Arnesen, Harald, Tønnessen, Theis, Solheim, Svein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833236/
https://www.ncbi.nlm.nih.gov/pubmed/36644557
http://dx.doi.org/10.1016/j.athplu.2022.03.005
_version_ 1784868195084009472
author Åkra, Sissel
Seljeflot, Ingebjørg
Braathen, Bjørn
Bratseth, Vibeke
Hansen, Charlotte Holst
Arnesen, Harald
Tønnessen, Theis
Solheim, Svein
author_facet Åkra, Sissel
Seljeflot, Ingebjørg
Braathen, Bjørn
Bratseth, Vibeke
Hansen, Charlotte Holst
Arnesen, Harald
Tønnessen, Theis
Solheim, Svein
author_sort Åkra, Sissel
collection PubMed
description BACKGROUND AND AIMS: Epicardial and pericardial adipose tissue (EAT and PAT) associate with atherosclerosis, however, discussed to have different inflammatory properties. We examined the NLRP3 inflammasome related pathway, playing a pivotal role in atherosclerosis, in EAT, PAT and subcutaneous AT (SAT), their relationship to cell types and anthropometric measures in patients undergoing coronary artery bypass grafting. METHODS: Biopsies from EAT, PAT and SAT were collected from 52 patients with coronary heart disease (CHD) (median body weight 85.0 kg) and 22 controls. RNA was extracted and expression of interleukin (IL)-1β, IL-18, NLRP3, Caspase-1, toll-like receptor 4 (TLR4), IL-6, IL-6 receptor and gp130 were analyzed by RT-PCR. RESULTS: Limited differences in any genes between CHD patients and controls. IL-18 and IL-6 were 4-fold higher expressed in EAT versus PAT (p < 0.01, both) and SAT (p < 0.001, both), whereas caspase-1, IL-6R and gp130 were higher expressed in SAT compared to the other compartments (all p = 0.06-<0.001). Significant correlations between SAT and PAT gene expressions (r = 0.358–0.579, all p ≤ 0.01). Especially NLRP3 and TLR4 associated with the expression of macrophages in all compartments (all p < 0.001). In EAT IL-18 correlated inversely with the expression of macrophages and T-cells. In SAT and PAT most of the mediators associated with body weight. CONCLUSIONS: Higher expression of IL-18 and IL-6 was observed in EAT in our non-obese CHD patients, not related to inflammatory cells. The NLRP3 inflammasome activation in SAT that mirrored PAT, both related to anthropometrics, suggest that SAT samples, being easily available, to a certain degree, represent adipose tissue inflammation in general.
format Online
Article
Text
id pubmed-9833236
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-98332362023-01-12 The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery Åkra, Sissel Seljeflot, Ingebjørg Braathen, Bjørn Bratseth, Vibeke Hansen, Charlotte Holst Arnesen, Harald Tønnessen, Theis Solheim, Svein Atheroscler Plus Full Length Article BACKGROUND AND AIMS: Epicardial and pericardial adipose tissue (EAT and PAT) associate with atherosclerosis, however, discussed to have different inflammatory properties. We examined the NLRP3 inflammasome related pathway, playing a pivotal role in atherosclerosis, in EAT, PAT and subcutaneous AT (SAT), their relationship to cell types and anthropometric measures in patients undergoing coronary artery bypass grafting. METHODS: Biopsies from EAT, PAT and SAT were collected from 52 patients with coronary heart disease (CHD) (median body weight 85.0 kg) and 22 controls. RNA was extracted and expression of interleukin (IL)-1β, IL-18, NLRP3, Caspase-1, toll-like receptor 4 (TLR4), IL-6, IL-6 receptor and gp130 were analyzed by RT-PCR. RESULTS: Limited differences in any genes between CHD patients and controls. IL-18 and IL-6 were 4-fold higher expressed in EAT versus PAT (p < 0.01, both) and SAT (p < 0.001, both), whereas caspase-1, IL-6R and gp130 were higher expressed in SAT compared to the other compartments (all p = 0.06-<0.001). Significant correlations between SAT and PAT gene expressions (r = 0.358–0.579, all p ≤ 0.01). Especially NLRP3 and TLR4 associated with the expression of macrophages in all compartments (all p < 0.001). In EAT IL-18 correlated inversely with the expression of macrophages and T-cells. In SAT and PAT most of the mediators associated with body weight. CONCLUSIONS: Higher expression of IL-18 and IL-6 was observed in EAT in our non-obese CHD patients, not related to inflammatory cells. The NLRP3 inflammasome activation in SAT that mirrored PAT, both related to anthropometrics, suggest that SAT samples, being easily available, to a certain degree, represent adipose tissue inflammation in general. Elsevier 2022-03-24 /pmc/articles/PMC9833236/ /pubmed/36644557 http://dx.doi.org/10.1016/j.athplu.2022.03.005 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Full Length Article
Åkra, Sissel
Seljeflot, Ingebjørg
Braathen, Bjørn
Bratseth, Vibeke
Hansen, Charlotte Holst
Arnesen, Harald
Tønnessen, Theis
Solheim, Svein
The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery
title The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery
title_full The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery
title_fullStr The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery
title_full_unstemmed The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery
title_short The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery
title_sort nlrp3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery
topic Full Length Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833236/
https://www.ncbi.nlm.nih.gov/pubmed/36644557
http://dx.doi.org/10.1016/j.athplu.2022.03.005
work_keys_str_mv AT akrasissel thenlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery
AT seljeflotingebjørg thenlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery
AT braathenbjørn thenlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery
AT bratsethvibeke thenlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery
AT hansencharlotteholst thenlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery
AT arnesenharald thenlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery
AT tønnessentheis thenlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery
AT solheimsvein thenlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery
AT akrasissel nlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery
AT seljeflotingebjørg nlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery
AT braathenbjørn nlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery
AT bratsethvibeke nlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery
AT hansencharlotteholst nlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery
AT arnesenharald nlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery
AT tønnessentheis nlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery
AT solheimsvein nlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery